West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 791,300 | 484,600 | 853,900 | 894,300 | 762,600 |
| Receivables | 574,400 | 552,500 | 512,000 | 507,400 | 489,000 |
| Inventories | 443,900 | 377,000 | 434,700 | 414,800 | 378,400 |
| Other current assets | 168,600 | 124,000 | 135,800 | 103,000 | 112,000 |
| TOTAL | $1,978,200 | $1,538,100 | $1,936,400 | $1,919,500 | $1,742,000 |
| Non-Current Assets | |||||
| PPE Net | 1,726,400 | 1,581,600 | 1,413,300 | 1,158,300 | 1,057,500 |
| Investments And Advances | 212,300 | 202,100 | 210,000 | 204,900 | 207,700 |
| Intangibles | 117,600 | 116,800 | 123,600 | 125,700 | 132,900 |
| Other Non-Current Assets | 235,500 | 204,800 | 146,200 | 208,400 | 173,700 |
| TOTAL | $2,291,800 | $2,105,300 | $1,893,100 | $1,697,300 | $1,571,800 |
| Total Assets | $4,270,000 | $3,643,400 | $3,829,500 | $3,616,800 | $3,313,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 253,700 | 239,300 | 242,400 | 215,400 | 232,200 |
| Accrued Expenses | 135,900 | 73,500 | 105,900 | 101,600 | 116,300 |
| Other current liabilities | 214,500 | 188,200 | 155,200 | 183,800 | 165,800 |
| TOTAL | $654,900 | $550,400 | $671,800 | $519,000 | $594,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 202,800 | 202,600 | 72,800 | 206,700 | 208,800 |
| Other Non-Current Liabilities | 199,800 | 172,200 | 172,600 | 172,800 | 141,700 |
| TOTAL | $439,100 | $410,700 | $276,700 | $412,900 | $384,300 |
| Total Liabilities | $1,094,000 | $961,100 | $948,500 | $931,900 | $978,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 72,304 | 73,299 | 74,136 | 74,282 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,800 | 18,800 |
| Retained earnings | 4,374,900 | 3,956,600 | 3,523,400 | 2,987,800 | 2,456,700 |
| Other shareholders' equity | -105,700 | -258,200 | -143,400 | -182,900 | -159,100 |
| TOTAL | $3,176,000 | $2,682,300 | $2,881,000 | $2,684,900 | $2,335,400 |
| Total Liabilities And Equity | $4,270,000 | $3,643,400 | $3,829,500 | $3,616,800 | $3,313,800 |